FOS and Dravet syndrome: Therefore, further investigations utilizing DS-derived induced pluripotent stem cells (iPSCs) and animal models, in combination with additional functional tests, may provide more definitive conclusions regarding the role of AP-1 and potential therapeutic interventions for DS.